1h Free Analyst Time
The point-of-care testing (poct) market in the US is forecasted to grow by USD 12.35 billion during 2025-2030, accelerating at a CAGR of 9.6% during the forecast period. The report on the point-of-care testing (poct) market in the US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising burden of chronic diseases, integration of digital telehealth platforms, decentralization of healthcare delivery models.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The point-of-care testing (poct) market in the US is segmented as below:
By Type
- OTC testing
- Prescription-based testing
By Application
- Blood glucose testing
- Infectious diseases testing
- Cardiac markers testing
- Pregnancy and fertility testing
- Others
By Product Type
- Immunoassays
- Clinical chemistry assays
- Nucleic acid amplification testing
- Hematology
- Cell-based assays
By Region
- North America
- US
The report on the point-of-care testing (poct) market in the US covers the following areas:
- Point-of-care testing (poct) market in the US sizing
- Point-of-care testing (poct) market in the US forecast
- Point-of-care testing (poct) market in the US industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Market Segmentation by Application
10 Market Segmentation by Product Type
11 Customer Landscape
12 Drivers, Challenges, and Opportunity
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global point-of-care testing (poct) market in us: Abbott Laboratories, ACON Laboratories Inc., Beckman Coulter Inc., Becton Dickinson and Co., Binx Health Inc., BioMerieux SA, Cepheid Inc., Chembio Diagnostics Inc., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Nova Biomedical Corp., OPTI Medical Systems Inc., OraSure Technologies Inc., PTS Diagnostics, QuidelOrtho Corp., Sekisui Diagnostics LLC, Siemens Healthineers AG, Trinity Biotech Plc, Werfenlife SA.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is decentralization of diagnostic testing services."
According to the report, one of the major drivers for this market is the rising burden of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- ACON Laboratories Inc.
- Beckman Coulter Inc.
- Becton Dickinson and Co.
- Binx Health Inc.
- BioMerieux SA
- Cepheid Inc.
- Chembio Diagnostics Inc.
- Danaher Corp.
- EKF Diagnostics Holdings Plc
- F. Hoffmann La Roche Ltd.
- Nova Biomedical Corp.
- OPTI Medical Systems Inc.
- OraSure Technologies Inc.
- PTS Diagnostics
- QuidelOrtho Corp.
- Sekisui Diagnostics LLC
- Siemens Healthineers AG
- Trinity Biotech Plc
- Werfenlife SA
